Latest Intelligence

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
NewsWire
NewsWire

MGC Diagnostics reports Q3 net loss

MGC Diagnostics Corporation has reported that net loss for the third quarter ended July 31, 2014 was $889,000, or $0.21 loss per share, compared to a net income of $652,000, or $0.16 per share, for the same quarter ended July 31, 2013.

Published By MarketLine
15 Sep 2014
NewsWire
NewsWire

Baxter announces launch of new biopharmaceutical company

Baxter International Inc., a diversified healthcare company, has announced the launch of a new, publicly traded biopharmaceutical company, Baxalta Incorporated, in mid-2015.

Published By MarketLine
15 Sep 2014
NewsWire
NewsWire

Peninsula Health announces construction on Rosebud dental clinic

Peninsula Health, a health care provider, has announced the construction on its Rosebud dental clinic with plans to open it in December 2014. The new dental clinic will expand from four to six dental chairs.

Published By MarketLine
15 Sep 2014
NewsWire
NewsWire

Phoebe Putney selects Harris to implement Provider Portal solution

Phoebe Putney Health System has selected Harris Corporation to implement its Provider Portal solution.

Published By MarketLine
15 Sep 2014
NewsWire
NewsWire

Revenio appoints CEO of Boomeranger Boats

Revenio Group Oyj, a healthcare technologies company, has appointed Riku Lamppu, segment director, as CEO of Boomeranger Boats Oy.

Published By MarketLine
15 Sep 2014
NewsWire
NewsWire

Biotest completes patient enrollment in Phase IIb rheumatoid arthritis study

Biotest, a provider of biological medications, has completed patient enrollment in the Phase IIb study assessing the efficacy and safety of tregalizumab in patients with moderate to severe rheumatoid arthritis.

Published By MarketLine
15 Sep 2014
NewsWire
NewsWire

Thoratec initiates enrollment of patients in heart failure trial

Thoratec Corporation, a provider of device-based mechanical circulatory support therapies, has initiated the enrollment of patients in the HeartMate III US clinical trial for heart failure.

Published By MarketLine
15 Sep 2014
NewsWire
NewsWire

Auxilium announces corporate restructuring to streamline operations

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, has announced corporate restructuring, reportedly designed to streamline operations.

Published By MarketLine
15 Sep 2014
NewsWire
NewsWire

Plexus to provide design and manufacturing solutions to Microsaic Systems

Plexus Corp., a provider of product realization solutions, and Microsaic Systems plc, a developer of chip-based scientific instruments, have entered an agreement for Plexus to provide design and manufacturing solutions from its UK facilities.

Published By MarketLine
15 Sep 2014
NewsWire
NewsWire

Valeant expands Bausch + Lomb contact lens manufacturing facility in Rochester

Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, has opened a new Bausch + Lomb ULTRA contact lens manufacturing lines and solar array assembly at its Optics Center in Rochester, New York.

Published By MarketLine
12 Sep 2014

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.